Karl Hansson , Rahil Dahlén , Oskar Hansson , Elin Pernevik , Ross Paterson , Jonathan M. Schott , Nadia Magdalinou , Henrik Zetterberg , Kaj Blennow , Johan Gobom
{"title":"“利用脑脊液中tau蛋白与肽的比值改善阿尔茨海默病的诊断分类”的勘误表[临床。质谱。14 (B部分)(2019)74-82]","authors":"Karl Hansson , Rahil Dahlén , Oskar Hansson , Elin Pernevik , Ross Paterson , Jonathan M. Schott , Nadia Magdalinou , Henrik Zetterberg , Kaj Blennow , Johan Gobom","doi":"10.1016/j.jmsacl.2022.08.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":52406,"journal":{"name":"Journal of Mass Spectrometry and Advances in the Clinical Lab","volume":"26 ","pages":"Page 35"},"PeriodicalIF":3.1000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f7/7d/main.PMC9523399.pdf","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]\",\"authors\":\"Karl Hansson , Rahil Dahlén , Oskar Hansson , Elin Pernevik , Ross Paterson , Jonathan M. Schott , Nadia Magdalinou , Henrik Zetterberg , Kaj Blennow , Johan Gobom\",\"doi\":\"10.1016/j.jmsacl.2022.08.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":52406,\"journal\":{\"name\":\"Journal of Mass Spectrometry and Advances in the Clinical Lab\",\"volume\":\"26 \",\"pages\":\"Page 35\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f7/7d/main.PMC9523399.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Mass Spectrometry and Advances in the Clinical Lab\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667145X22000335\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Mass Spectrometry and Advances in the Clinical Lab","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667145X22000335","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]